Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H22O8 |
Molecular Weight | 342.3411 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=CC(\C=C\CO)=C1
InChI
InChIKey=SFLMUHDGSQZDOW-FAOXUISGSA-N
InChI=1S/C16H22O8/c1-22-11-7-9(3-2-6-17)4-5-10(11)23-16-15(21)14(20)13(19)12(8-18)24-16/h2-5,7,12-21H,6,8H2,1H3/b3-2+/t12-,13-,14+,15-,16-/m1/s1
DescriptionSources: http://www.hmdb.ca/metabolites/HMDB13682Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/17396961 and https://www.ncbi.nlm.nih.gov/pubmed/11345691
Sources: http://www.hmdb.ca/metabolites/HMDB13682
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/17396961 and https://www.ncbi.nlm.nih.gov/pubmed/11345691
Coniferin is a glucoside of coniferyl alcohol. It is a metabolite in conifers, serving as an intermediate in cell wall lignification, as well as having other biological roles. Coniferin displays moderate anti-inflammatory properties.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11345691 |
75.2 µM [IC50] | ||
Target ID: map00590 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11345691 |
63.6 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11345691
In vitro effect of coniferin wastested for interactions with the cyclo-oxygenase and 5-lipoxygenase pathways of arachidonate metabolism in calcium-stimulated mouse peritoneal macrophages and human platelets. In these experiments coniferin produces reduction in generation of both cyclo-oxygenase (IC50 values 75.2 microM for prostaglandin E2 and 619 microM for thromboxane B2) and 5-lipoxygenase metabolites, but the effects are greater against leukotriene C4 (IC50 value 63.6 microM).
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m3757
Created by
admin on Fri Dec 15 19:41:56 GMT 2023 , Edited by admin on Fri Dec 15 19:41:56 GMT 2023
|
PRIMARY | Merck Index | ||
|
CONIFERIN
Created by
admin on Fri Dec 15 19:41:56 GMT 2023 , Edited by admin on Fri Dec 15 19:41:56 GMT 2023
|
PRIMARY | |||
|
C016316
Created by
admin on Fri Dec 15 19:41:56 GMT 2023 , Edited by admin on Fri Dec 15 19:41:56 GMT 2023
|
PRIMARY | |||
|
16220
Created by
admin on Fri Dec 15 19:41:56 GMT 2023 , Edited by admin on Fri Dec 15 19:41:56 GMT 2023
|
PRIMARY | |||
|
531-29-3
Created by
admin on Fri Dec 15 19:41:56 GMT 2023 , Edited by admin on Fri Dec 15 19:41:56 GMT 2023
|
PRIMARY | |||
|
M6616XLU2J
Created by
admin on Fri Dec 15 19:41:56 GMT 2023 , Edited by admin on Fri Dec 15 19:41:56 GMT 2023
|
PRIMARY | |||
|
5280372
Created by
admin on Fri Dec 15 19:41:56 GMT 2023 , Edited by admin on Fri Dec 15 19:41:56 GMT 2023
|
PRIMARY | |||
|
DTXSID201023811
Created by
admin on Fri Dec 15 19:41:56 GMT 2023 , Edited by admin on Fri Dec 15 19:41:56 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD